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THE UNIVERSITY OF TENNESSEE
COLLEGE OF VETERINARY MEDICINE

July 15, 1994

Office of the Dean
P. O. Box 1071
Knoxville, TN 37901-1071

(615) 974-7262

The Center of Excellence in Livestock Diseases and Human Health has
completed another productive year. This success can be traced to the Center's
continuing efforts to focus on selected areas of emphasis, support the most
productive projects, and invest in only the most promising young investigators
and new projects. Again this year recommendations by both the external and
internal advisory committees have provided the scientific basis for both policy
and technical decisions made by the Center.
While the Center supported projects in the areas of Inflammation and Host
Defense, as well as Infectious Diseases and PopUlation Medicine, this past year
particular emphasis was placed on Growth Factors and In Vitro Toxicology.
With this emphasis two new faculty members will be part of the Center as of
July 1994. Dr. Joyce Merryman will join the Growth Factor group. Dr. Daniel
Ward will join the In Vitro Toxicology and Toxicokenetics group. Therefore,
capital equipment purchases were targeted toward these groups.
A multiuser in vitro toxicology laboratory was the result of College Renovations.
Equipment for this facility was purchased with Center funds. A large
sterilization unit was also purchased. Although the sterilizer may be used by
all members of the College, it will directly benefit the Growth Factor Group.
Continued support of the Center will assist us in research focused on livestock
disease and human health which is important to the region, the State of
Tennessee and the nation as a whole. This coming year we will continue to do
the things we do with excellence as evident by the projects headed by Drs.
Bochsler, Brian, McDonald, Potgieter, Rouse, Schuller, and Wilkinson.
We will continue to place a premium on projects using modern molecular
biological techniques because they hold the greatest promise for extramural
funding. We also plan to strengthen our research in the area of applied
molecular genetics and our interaction with Oak Ridge National Laboratory.
Therefore, we have renamed the Growth Factor Group the Growth Factor and
Molecular Genetics Group.
We end this year and look forward to the next with a successful Center, in large
part due to a diligent and competent core of faculty and staff dedicated to
excellence in research in livestock disease and human health.

,/------._!

\ G.M.H. Shires
Dean-and Director of the Center
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I. PROGRAMMATIC REPORT
LA.

RENAMING OF A RESEARCH GROUP

One of the five major research groups, Growth Factors, has been renamed Growth
Factors and Molecular Genetics. This name change reflects the Group's and Center's
emphasis on molecular genetics and the expanded interaction with the Molecular
Genetics group of the Biology Division of Oak Ridge National Laboratory. This
interaction is coordinated by DRS. E. WILKINSON and D. SLAUSON. The area of
molecular genetics focuses on the characterization of the role of specific genes in
important diseases in mutants, especially mice. Involved in this is the phenotypic,
cellular, and molecular analysis of spontaneous mutants, insertional mutants, saturation
mutants, knockouts, and traditional transgenic animals. Studies such as these use all the
tools of modern molecular biology, as well as the traditional tools of immunology,
pathology, and developmental biology to completely evaluate the role of specific genes in
specific diseases.
I.B.

PERSONNEL CHANGES

I.B.I. Personnel Additions
A. WARD joins the "In Vitro Toxicology and Toxicokinetics"
(lVTT) group. He received his D.V.M. from The University of Tennessee and his
Ph.D. from the University of Georgia.
DR. JOYCE I. MERRYMAN joins the "Growth Factors and Molecular
Genetics" (GFMG) group. She received both her D.V.M. and Ph.D. from The
Ohio State University.
DR. DANIEL

I.B.2. Personnel Deletions
None

I.e.

CENTER GOALS AND MAJOR PROGRAMMATIC ACTIVITY
GOAL

I: To IMPROVE THE QUALITY OF HUMAN LIFE THROUGH BETTER ANIMAL
HEALTH .

Research performed by DR. J. GODKIN in conjunction with DR. L. MUNSON has
focused on fetal-maternal interactions that contribute to the maintenance of pregnancy
and growth and development of the embryo in domestic farm animals. This work has led
to a new Department of Agriculture grant which began this year.. This past year, studies
were completed on the fetal-maternal interactions between the embryonic protein
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interferon tau ('t) believed to be the embryonic signal that mediates the maintenance of
early pregnancy in ruminants. Two uterine cell culture systems were established, and it
was demonstrated that recombinant bovine IFN't inhibited, and oxytocin stimulated,
uterine epithelial cell production of prostaglandins (PG) F2u and E2 but had no
measurable effects on stromal cells. In addition, IFN't had no effect on uterine cell
protein production or PG synthase mRNA production. Results demonstrate that IFN't
maintains early pregnancy by inhibiting uterine epithelial cell production of PGF2u.
This action maintains pregnancy through maintenance of progesterone production by the
corpus luteum which is susceptible to regression mediated by PGF2u.
Expression oftransforming growth factor-beta (TGF-~), a potent regulator ofcell
growth, was identified and characterized in ovine and bovine uterine endometrium and
embryos. TGF -~ 1 and ~2 was identified in tissues by immunocytochemical procedures
and TGF-~l, ~2 and ~3 mRNA's were quantitated by scanning densitometry of slot blots.
Each TGF-~ isoform exhibited different temporal and tissue specific expression
suggesting unique functions. IFN't was shown to diminish uterine TGF -~ expression.
Retinol-binding protein (RBP), the vitamin A transport protein, was discovered to
be a product of ovine and bovine blastocysts, placental membranes and uterine
endometrium. Expression of RBP and its mRNA was identified in tissues by
immunocytochemistry and in sill! hybridization procedures. Changes in the level of
mRNA expression in uterine and conceptus tissues were quantitated by scanning
densitometry of slot blots.
Expression of conceptus RBP was shown to be
developmentally regulated, while uterine RBP expression was modulated by ovarian
steroids and the conceptus protein, IFN't.

GOAL 2: To AUGMENT LIVESTOCK DISEASE RESEARCH CAPABILITIES IN THE
INSTITUTE OF AGRICULTURE.

P. BOCHSLER and DR. D. SLAUSON continue their studies of the response of
cattle to the presence of gram-negative bacterial pathogens, particularly one of the toxins
released by these bacteria. Bacteria of this type are known to be responsible for several
types of clinical disease of cattle, including forms of pneumonia, mastitis, and diarrhetic
disease. The toxin they study is referred to as endotoxin or LPS, and it incites fever,
depression, and other clinical symptoms in cattle, and may cause or contribute to causes
of death. They have made significant progress in identification of some of the pathways
and mediators that are important in the response of cattle to endotoxin. A few of the
results of these studies include identification of a bovine serum LPS-binding protein that
is important in the response to endotoxin/LPS, and study of mediators of inflammatory
disease in cattle, such as TNF u and tissue factor.
DR.
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GOAL 3: To IDENTIFY AND CHARACTERIZE ANIMAL DISEASES THAT ARE
ANALOGOUS TO HUMAN DISEASES.
DR. S. MENDIS-HANDAGAMA has continued her basic research on the role of
peroxisomes in the steroidogenic process that was investigated using primarily Leydig
cells in vivo in adult rats. Previously, her research has shown that sterol carrier protein-2
(SCP2), which binds to cholesterol in 1: 1: molar ratio is highly concentrated in Leydig
cell peroxisomes. Continuation of this line of research has recently revealed yet
undiscovered aspects in the pathway of steroidogenesis in general, and particularly in
Leydig cells. The results showed that with acute luteinizing hormone (LH) stimulation:
(a) SCP2 gets highly concentrated in Leydig cell peroxisomes (5-fold above control
values); (b) this is due to redistribution and not due to ~ novo synthesis of SCP2', (c)
peroxisomes rich in SCP2 fuse with Leydig cell mitochondria and, (d) this fusion of
peroxisomes and mitochondria is associated with transfer of SCP2 into mitochondria.
Whether SCP2 delivers cholesterol at the inner mitochondrial membrane, or
whether SPC2 could travel into the mitochondria with cholesterol was an unresolved
issue in the process of steroidogenesis. Though tissue differences are possible, her
studies showed for the first time that in steroidogenic cells in the testis, SCP 2 moves into
mitochondria with LH stimulation, suggesting that SCP2 delivers cholesterol into the
inner mitochondrial membrane for side chain cleavage reaction to product pregnenolone.
Moreover, these studies revealed for the first time that peroxisomes are responsible for
this mechanism of cholesterol transport during steroid hormone biosynthesis in Leydig
cells. This work has lead to Dr. S. Mendis-Handagama receiving this year a National
Science Foundation grant to continue her work on understanding the mechanisms
involved in movement ofperoxisomes towards mitochondria for cholesterol delivery.
During the past year DR. R. SHULL continued work on his long-term program
aimed at discovering effective novel therapy for canine MPS I, a model of the same
disease in children. A total of 6 gene transfer/gene therapy experiments were conducted
utilizing 4 MPS I-affected dogs and 3 unaffected animals. The initial goal was to
document survival of hematopoietic stem cells in long-term bone marrow culture after
infection with a retroviral vector carrying the gene for the enzyme missing MPS I. In
later experiments, transfected cells were returned to 2 affected dogs and evidence of in
vivo gene expression sought. Initial results were not encouraging, as has been the
experience at other institutions where similar work on gene therapy in large animal
species is being conducted. In collaboration with individuals at the University of
Toronto, Canada, a third dog was treated with cells modified genetically in a long-term
culture system. Results of these studies are still being collected at this time, but evidence
of at least intermittent enzyme production has been found . Six MPS I-affected dogs were
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also treated by intravenous infusion of recombinant human enzyme. These trials were
successful in documenting that human enzyme could be taken up by canine cells and that
it could have dramatic effects in some tissues on the abnormal storage products that are
typical of the untreated disease.
DR. T. SCHULTZ has completed studies aimed at predicting the toxicity of
oxygen-containing aliphatic and aromatic industrial chemicals. This work was designed
to develop mathematical models that predict the toxicity of chemicals from their
molecular structure and, thus, eliminating the need to test them on animals. This past
year, work centered on examining the toxicity of esters including benzoates and
phthalates. The investigations have shown that in animals with high esterase activity,
esters are more toxic than in animals with low esterase active. Moreover, when toxicity
was corrected for this activity and a volume fraction analyses performed, a technique
developed by Dr. Schultz's group, toxicity can be attributed to the nonpolar narcosis
mechanism ofaction. This information goes a long way in explaining the highly variable
toxicity data for esters reported in the literature.

GOAL 4: To STUDY ANIMAL MODELS FOR BETTER UNDERSTANDING OF HUMAN DISEASE.
DR. H. SCHULLER'S

research programs in the area of lung tumors has continued
to do very well. Among the findings of Dr. Schuller's laboratory is that women who
smoke during pregnancy genetically predispose their children to lung tumors as the
children become adults. Since not all lung tumors are the result of smoking, research is
expanding to determine how other pollutants impact the development of lung cancer.
Moreover, Dr. Schuller's research has been to develop a neuroendocrine lung
carcinogenesis model in hamsters. She has determined the etiology of the model.
Moreover, in collaboration with Byk Guldden Pharmaceuticals, she and DR. K. HAHN
evaluated a novel calcium channel blocker, Dexniguldipine, which inhibits tumor cell
growth. This agent is currently in animal and human clinical trials.
The main objective during the past year for DR. B. ROUSE was to understand the
role of various cytokines in the immunopathogenesis of herpetic stromal keratitis (HSK).
Previous studies from the laboratory have shown the predominant role of Th 1 derived
cytokines. This was done by isolating cells from the eye and stimulating them in vitro in
various ways. While this could be a true representation of events in vivo, there is still a
possibility that in Yi1m manipUlations influencing the cytokine profile. Hence, in order to
obtain a better picture of in vivo events, they examined the cytokine mRNA profile in
total cellular RNA from cells isolated from the cornea. For this, they developed a highly
sensitive and specific quantitative competitive reverse transcription polymerase chain
reaction (RT-Q-PCR). The development of this approach was essential since the
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cytokine mRNA in vivo is in low abundance and the number of cells that can be obtained
from the mouse cornea is very limited. The detailed methodology has been published in
an immunologicaljoumal. Essentially, the quantitation relies on the competition of target
DNA and internal control DNA for all the reactants including the primer sets.
The cytokine gene expression study was extended to an extremely valuable but
expensive model, namely the SCID mouse, which was reconstituted to generate HSK
with T cells from immune or naive mice (2). Overall, the SCID mouse data was
consistent with immunocompetent mice. In general, the in vivo cytokine gene expression
analyses during HSK demonstrated a clear role for Th-I derived cytokines and it appears
that IFN -'t is the potent inflammatory mediator in the cornea.
Using this approach, they examined the inflammatory and T cell derived cytokine
mRNA levels in both immunocompetent and reconstituted SCID mouse during the course
of HSK development. Their data show that with regard to inflammatory cytokines, in
both draining lymph nodes (DLN) and cornea, IL-I , IL-6, TNFa mRNA were expressed
in relation to the clinical severity during the onset and clinical phases of HSK. There was
a dramatic influx of TNFa in the more severe clinical lesions. The concentration of
inflammatory cytokines were more in the ocular tissue over the DLN. With regard to the
T cell derived cytokines, there were two surges in both DLN and ocular cells. One
confined to early phase at 7-day post infection and other to the clinical phase. In the
DLN, both Thl and Th2 were seen, but Thl predominated. In the ocular tissues, a
transient ThO type (11-2, IFN't, IL-4) was evident in the early phase. Later phase in the
ocular tissue was confined to the Th 1 pattern.
Presently, Dr. Rouse and his co-workers are working on in situ hybridization
method in order to further characterize the cytokine profile (gene expression) and viral
gene expression during the course of HSK. This is to identify and localize the cells
involved in the immunopathology of HSK. Towards this end, they have developed
specific probes for detection of viral genes, inflammatory cytokine genes and T cell
derived cytokine genes. They have standardized the methodology for the detection of gB
(viral gene), IL-2, IFN-'t, IL-6 mRNA in cells prepared by cytospin. Studies are in
progress in order to apply this procedure to sections of cornea obtained during various
stages of the development of HSK.
DR. M. MILLER in conjunction with DR. H. SCHULLER has been examining the
role of oncogens in transplacental carcinogenesis. One goal of this research project was
to adapt the polymerase chain reaction technique to amplify small quantities of DNA
from paraffin-embedded tissues. This has been successfully done, and amplified
sequences of the hamster Ki-ras gene obtained. In dose response experiments, a readily
detectable signal was obtained by Southern blot analysis of the amplified DNA in less
than 24 hours of autoradiographic exposure from as little as the equivalent of a 1 micron
piece of tissue from embedded hamster lung samples. This technique was pivotal to Dr.
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M. Miller' s success this year in obtaining a National Institutes of Health grant to examine
the role of oncogens in transplacental carcinogenesis in the mouse model. During this
past year, Dr. M. Miller has trained Dr. Schaeffer and her technical staff on the proper
way to perfonn the high i.p. injections on pregnant mice. They have established a
breeding colony and set up an excellent record keeping system to track the mice through
the one-year study. They have initiated the carcinogenicity bioassay and have filled the
first treatment group. As noted earlier, his previous research on gene mutations were
conducted in hamsters. Thus, he has also used COE support to purchase amplimers to the
mouse Ki-ras gene and have amplified DNA by the standard procedures described in the
literature and obtained very good results. His group are also standardizing our research
protocols to extract DNA from paraffin embedded mouse tissues. Thus, when the mouse
bioassay is completed and the mice are euthanized, they will be ready to begin the
molecular biology analysis immediately. Use of the COE funds has thus allowed him to
optimize the reaction conditions early in the study, which will save him a great deal of
time later.
During the past year, DR. E. WILKINSON has continued to make great strides in
characterizing the cells from Tg737 mice that are responsible for development of the
kidney and liver lesion in this transgenic mouse model of autosomal recessive polycystic
kidney disease. This work is in conjunction with investigators at the Biology Division of
Oak Ridge National Laboratory. In general, studies continue to further define normal
structure and function of the Tg737 gene, determine how mutations in the gene result in
the pathological changes seen in the disease and to identify other genes associated with
expression of the disease . Specific examples have been included. Dr. Wilkinson's
laboratory has begun an analysis of the ability of transformed cells from previously
isolated cell lines to produce both hepatocellular carcinomas and cholangiocarcinomas
in mice. These studies involved both the transplantation of transformed oval cells into
nude mice and the treatment of mutant mice with hepatic carcinogens. They have
generated transgenic mice that express the Tg737 gene from a different promoter and
used these mice to correct the defect in the kidney but not in the liver of offspring of
mutant mice bred to transgenic mice. Moreover, they are now using these "phenotype
rescued" mice to evaluate the log tenn effects of the liver lesion on the health of the
animals and to utilize these animals for studies of the role of oval cells in liver cancer. In
addition, collaborative efforts have also generated data to suggest that the Tg 737 gene
may be involved in liver cancer. Mutations in the Tg737 gene have been found in a high
percentage of chemically induced liver tumors in rodents. Further work by. Dr.
Wilkinson's group this past year completed the analysis of the FVB TgN737Rpw mice.
This work described the detailed pathology ofthe kidney and liver lesions.
In another collaborative project, DR. B. ROUSE ' S laboratory with DR. E.
WILKINSON ' S laboratory have recently completed an analysis of the cellular basis for the
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severe lymphoproliferative disease in scurfy mIce. These investigations utilized a
number of "knockout" mice that lacked important molecules involved in the normal
immune response The X-linked recessive mutation scurfy (sf) results in a phenotype
characterized by a rapidly fatal immune disorder involving the skin and lymphoid
systems. In order to understand better the immunobiology of the scurfy mouse, they have
undertaken a series of experiments that investigate the role of the thymus and its
components in the etiology and expression of scurfy disease. A few of the several
important observations are noted. Results from experiments involving the transplantation
of scurfy fetal thymi into H-2-compatible nude and SCID mice indicated that scurfy
disease acts upon the fetal thymic environment as early as day-14 in development. Other
experiments involving the selective transfer of wild-type or scurfy thymic components
demonstrated that both sf-derived T cell precursors, and a genetically sf thymic
microenvironment were necessary for disease expression. In addition, the roles of CD4
or CD8 single-positive T cells were evaluated. This was accomplished by treating scurfy
neonates with monoclonal antibodies directed against the CD4 or CD8 molecules and by
breeding the scurfy mutation onto mice that lacked either CD4+ or CD8+ T cells. Results
implicated CD4+ DC8- T cells as the critical effector cells in the pathogenesis of scurfy

disease .

GOAL

5:

To UNDERSTAND THE PATHOGENESIS AND CHARACTERIZE THE
CAUSATIVE AGENTS OF COMMON DISEASES IMPORTANT TO TENNESSEE.

Fescue toxicosis remains one of the most costly disease syndromes to Tennessee
beef producers. Studies in DR. J. OLIVER'S laboratory during the past year have
continued to focus on the mechanism(s) of toxic tall fescue alkaloids in cattle, using
alkaloid effects on blood vessels to project cause-and-effect relationships to the animal as
a whole.
During the past year, the mastitis research team in DR. S. OLIVER' S laboratory
has developed a technique using Instagene purification matrix for DNA isolation. This
technique is rapid, economical, and yields sufficiently pure DNA template for polymerase
chain reaction from both gram-negative and gram-positive bacteria for randomly
amplified polymorphic DNA (RAPD) fingerprinting. They also have evaluated 20
potential oligonucleotide primers for RAPD fingerprinting of 19 different reference
strains belonging to the family Enterobacteriaceae , and the genera Enterococcus,
Staphylococcus~ and Streptococcus. Criteria for selection of potential primers were based
on fingerprint patterns analyzed for number and size of RAPD fragments and absorbance
of fragments using gel analysis software. A proposed bacterial species identification
scheme was developed. This scheme will be helpful in identifying particular species

associated with a given mastitis case.
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Coronaviruses cause some of the most costly respiratory and gastroenteric
diseases in domestic livestock and fowl. Yet vaccines to control their spread are often not
effective because of the special challenges of inducing immunity at mucosal surfaces and
because coronaviruses mutate rapidly.
DR. D. BRIAN's laboratory investigates
coronaviruses that infect many animal species, including cows. By studying the
molecular biology of bovine coronavirus replication, Dr. Brian's laboratory has identified
potential sites in the viral genome for targeted antiviral therapy and uncovered two
potential mechanisms of persistent infection. Most excitingly, they have discovered a
subviral replicon that they have cloned and engineered to carry viral immunogens and
other potential antiviral or therapeutic molecules.

GOAL

6: To IMPROVE THE CAPABILITIES OF THE COLLEGE OF VETERINARY
MEDICINE, THE COLLEGE OF AGRICULTURE, AND THE AGRICULTURAL
EXPERIMENT STATION TO DEAL WITH THESE DISEASES.

Work continues on the molecular biology and immune response to bovine viral
diarrhea virus. DR. L. POTGIETER's laboratory has as their goal with BVDV research,
the development of improved diagnostics and immunoprophylaxis. Investigation focuses
on the structural proteins of this virus. These proteins are responsible for induction of the
protective immune response. The three major structural protein-encoding genes have
been cloned, analyzed, and expressed. Using these expression products, their goal is to
develop a sensitive and specific serological test that is very economical. Further, these
proteins may be subcloned into live virus vectors for use in recombinant live vaccines.
Antibodies induced by these proteins in animals were found to have neutralizing
capabilities. This pathogen is associated with respiratory and reproductive disease
leading to considerable financial loss. Improvement in these two areas ofBVDV control,
diagnosis and immunoprophylaxis, will have significant impact on the cattle industry.
Additionally, work is ongoing to evaluate the ovine respiratory syncytial virus at
the molecular level. The surface protein responsible for viral attachment and induction of
protective immunity to this virus, the G glycoprotein, has been cloned and sequenced,
and the nucleotide sequence has been extensively analyzed. The gene encoding the
non structural proteins 1a, 1b, and 1C of ORSV has also been cloned, sequenced, and
analyzed. This is the only ruminant RSV IA-C genes to be sequenced to date. Cloning
and sequencing of the G glycoprotein of ovine RSV adds to the information they have
from the bovine RSV . This knowledge will be useful for the development of sensitive
and specific diagnostic assays, as well as for the development of an effective vaccine.
Further, the analogy to the human RSV may prove to be very useful for development of a
suitable animal model for this significant human pathogen. This work is of interest to
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NIH, and we anticipate significant extramural funding next year. The sequencing of the
1C gene will also be important for guiding vaccine and diagnostic assay development.

GOAL

7:

To IMPROVE FACILITIES TO ENABLE THE COLLEGE OF VETERINARY
MEDICINE TO STUDY MORE EFFECTIVE INFECTIOUS AND TOXIC
DISEASES AFFECTING ANIMALS.

The COE research efforts are housed mainly in the Clyde M. York Veterinary
Medical Teaching Hospital. This building which also contains clinical and teaching
facilities faces a severe space shortage. While other collaborative research space is
located in McCord Hall (Animal Science), Walters Life Science Building (Microbiology),
and at The University of Tennessee Medical Center and Memorial Research Hospital
(Medical Biology), research space everywhere is a premium. Long-term plans forecast a
solution for this problem. However, in the short-term reorganization, and minor
renovation are the stop gap measures. Research laboratories are mulituser and generally
organized around specific research approaches and are usually shared among different
faculty with similar interests. Each laboratory contains state-of-the-art equipment
necessary for conducting high quality research. While the past several years have been
difficult ones from a fiscal standpoint and little funds have been available for the
expansion of facilities, the College this past year did undertake the renovation of a
laboratory to provide an up-to-date in Y.i1m toxicology laboratory COE funds provide the
new equipment for this facility. It was felt that this was pivotal to several of our younger
faculty and was part of the Center's commitment to the IVTT group.

GOAL

8:

To DISSEMINATE THROUGH THE EXTENSION SERVICE THE PRACTICAL
INFORMATION REQUIRED TO REDUCE THE INCIDENT OF LIVESTOCK DISEASES.

UTCVM has been featured in several publications over the course of the year. UT
Agriculture, published by the Institute of Agriculture and encompassing a large statewide
audience, featured articles by COE personnel. Veterinary Medical Topics, published
semi-annually by the Extension Service, routinely features articles exploring livestock
diseases. Regular features appear as well in the two UT alumni publications, Context and
the Torchbearer. Moreover, COE personnel routinely speak to state commodity groups.

GOAL

9:

To DEVELOP NEW STRATEGIES FOR THE PREVENTION OF DISEASE.

Several projects whose overall objectives are to determine the factors that induce
formation, maintenance and disruption of the blood-brain barrier and other organ specific
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toxicity are being conducted by center members. DR. T. ROWLES has begun developing
protocols for in Yitm testing and kinetics of neurotoxicants. Cytotoxicity assays in
endothelial, glial, and neuronal cells were established. Additionally, an in Yi1IQ model of
the blood-brain barrier is being developed by co-culturing these cell types. Work this
past year in collaboration with DR. D. FRAZIER suggests the astroglia and brain
capillary endothelial cells may interact in a complex biochemical network via mediators
such as cytokines and growth factors to modulate maintenance ofthe barrier.
Breast cancer is the leading cause of death in women ages 35 to 54. During the
past year, COE has supported DR. K. HAHN's research project aimed at improving the
therapeutic efficacy of chemotherapy in the clinical management of advanced stage breast
cancer. The hypotheses of this study is that the cellular response of normal and malignant
cells in vitro to alkylating cytotoxic drugs is influenced by differences in oxygenation,
pH, and glutathione concentration and cytotoxicity can be potentiated by etanidazole
sensitization.
Last years work focused on determining whether differences in
oxygenation in normal lymphocytes in vitro affected etanidazole sensitization of anti
neoplastic drugs such as bleomycin, doxorubicin HCI, and cis-diammine-dichloro
piatinumll. It was concluded that etanidazole sensitizes bleomycin, doxorubicin, and cis

platin cytotoxicity in hypoxic but not in aerobic Go lymphocytes. Moreover, bleomycin
and doxorubicin induction of micronuclei in etanidazole-sensitized hypoxic cells and
non-etanidazole-sensitized aerobic cells appears to be dose-dependent. In contrast,
cisplatin induction ofmicronuclei does not appear to be dose-dependent.

GOAL 10: To IMPROVE FACILITIES AND EXPERTISE IN ORDER TO PROVIDE IMPROVED
RESEARCH TRAINING.
SPECIAL MATERIALS AND EOUIPMENT
Equipment monies this year were spent on assisting with the establishment of
IVTT laboratory. This multiuser laboratory will service Center members--DRS. D.
FRAZIER, K. HAHN, T. ROWLES, and D. WARD. This mainly encompassed upgrade
tissue culture and chemical handling capabilities. As well, several multiuser pieces of
equipment were purchased, including a steam sterilization unit housed in the P-3 facility .
GRADUATE STUDENTS, POST DOCTORAL RESEARCHERS, AND RESIDENTS
Our training program remains small, but of high quality.

DRS. D. BRAIN, D.

FRAZIER, T. McDONALD, J. OLIVER, S. OLIVER, B. ROUSE, AND E. WILKINSON, each
had a graduate student and/or post-doctoral researcher supported by the Center.
An institutional training grant has been resubmitted by DR. D. SLAUSON,
Department of Pathology. If funded, it will support five graduate students/residents
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selected from the Comparative and Experimental Medicine Graduate Program. These
students will train in the area of "Cellular Pathobiology of Environmental Disease." The
program will be a collaborative effort between the Department of Pathology and the
Biology Division at Oak Ridge National Laboratory. The program will seek to produce
individuals who, by virtue of their training, will be uniquely equipped to address such
important environmental research priorities as the molecular and genetic basis for
disease, genetic and membrane events that may control differentiation and development,
the role of receptor-mediated pathobiology including transmembrane signal
transduction, molecular mechanisms of chemical carcinogenesis, and the molecular and
genetic basis for immunologic susceptibility and predisposition. The graduates of this
program should then be able to contribute to an enhanced understanding of the
environmentally-caused disorders of man and other animals, both in terms of the
morphologic expressions of disease and in terms of its molecular and cellular
pathogenesis.
Several young investigators continue to benefit from COE funds. Dr. Huda AI
Ansari continues her work on the significance of strain variation within the ruminant
respiratory syncytial viruses. Dr. Steve Kannia is in the third year of his investigations of
the protozoa Babesia bigmina which effects red blood cells of most domestic animals.
Dr. Melissa Kennedy is involved with examining the antibody response, viral clearance,
and clinical parameters associated with cattle vaccinated against bovine viral diarrhea
virus. Dr. Jill Sackman is working on a novel approach to vascular disease . Dr. Jim
Strickland has finished his second year on a tall fescue toxicosis project.
MINORITY RECRUITMENT

Through our minority internship/residency program, UTCVM has been successful
in recruiting 5 minorities for the upcoming fiscal year.
The veterinary internship for African-American High School Students in
Tennessee, developed with funding provided by a grant from the Tennessee Higher
Education Commission, is now in its second year. This program is very competitive with
applicants for the eight funded slots.
The Minority High School Apprentice Program sponsored by the National
Institutes of Health is currently in its 13th year. It is directed by a Center member DR. T.
SCHULTZ.
COLLABORATIVE RESEARCH PROJECTS

Collaborative research projects continue to be a hallmark of Center personnel,
especially those in the GFMG group. The role of genotype genomic imprinting and sex
hormones in platelet and megakaryocyte production is the topic of a new collaboration
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between DR. T. McDoNALD and Dr. Carl Jackson of St. Judes Medical Center in
Memphis.
DR. L. MUNSON continues her collaborations with the University of Washington,
Seattle to evaluate placental development in the Patch mouse. Molecular techniques are
being used to identify homozygous mutant embryos so that the development of their
placenta can be evaluated.
DR. R. SHULL continues his long-standing collaboration with Dr. Elizabeth
Neufeld of the University of California at Los Angeles. This work involves the
development and evaluation oftechniques in gene therapy.
In collaboration with Dr. Ellis Avner of the University of Washington, Seattle,
DR. E. WILKINSON is characterizing the kidney cells involved in the production of the
lesions in the Tg737 mice. In collaboration with Dr. Steve Reeders of Howard Hughes
Medical Institute, Yale University, Dr. Wilkinson is examining the structure of the Tg737
gene in over 100 human families with autosomal recessive polycystic kidney disease. In
addition, Dr. Wilkinson has a collaborative study with Dr. Greg Dressler of the National
Institutes of Health (NIH). This project examines the nature of the congenital nephrotic
syndrome in PAX-2 transgenic mice. Dr. Wilkinson's laboratory previously established
cultures of liver and kidney cells from Tg737 mice. To these have been added several
lines of liver cells and have been developed from mice with different genetic
backgrounds. Cooperative efforts between Oak Ridge National Laboratory and Proctor &
Gamblefurther characterize the putative liver stem cells ofthese cultures.
Collaborative work is not limited to the GFMG group. DR. T. SCHULTZ of the
IVTT group and researchers at the School of Pharmacy of John Moores-Liverpool
University in England are working on modeling toxicity of bioreactive toxicants.
Bioreactive toxicants are characterized by having strong stereo-electronic interaction
which appear to be best quantitated by molecular orbital quantum chemical parameters.
Moreover, Dr. Schultz in conjunction with Dr. Ovanes Mekenyan of the Higher Institute
of Chemical Technology, Bourgas, Bulgaria is examining a "dynamic" approach to
quantitative structure-activity relationships. By using high speed computers, they
develop thousands of three-dimensional conformers for a single two-dimensional
molecular structure. They are evaluating which conformers best model the activity ofthe
organic chemical.

GOAL 11: To DEVELOP INNOVATIVE APPROACHES TO THE TREATMENT OF HUMAN
DISEASE.

During the past year, COE provided support for a post-doctoral fellow to work
with DRS. D. FRAZIER and DR. T. ROWLES. The project looked to the development of
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cell culture protocols, singly and in co-culture, as a means to evaluate organ specific
toxicity of chemicals. Specifically neuroblastoma cells, brain capillary endothelial cells
astrocytes and kidney tubule cells. COE continues to provide support for two doctoral
students. The projects they are working on are complementary to others being worked on
by the IVTT group.
Earlier work by DR. T. McDoNALD showed that thrombopoietin significantly
increases megakaryocyte sizes and platelet counts of sublethally irradiated mice,
indicating that thrombopoietin will be useful in treating patients undergoing bone-marrow
transplantation and/or patients with platelet production problems. Moreover, Dr.
McDonald's group showed previously that C3H mice have higher average ploidy
megakaryocytes than other mouse strains tested, but the mode of inheritance of the
anomaly is unknown. Studies were carried out this past year in an effort to clarify the
genetics of high ploidy megakaryocytes in C3H mice. They measured megakaryocyte
DNA content for both male and female offspring from FI, as well as backcross matings.
The data revealed that polyploidy megakaryocytes DNA content distributions of the
offspring from the matings showed that C3H mice have higher percentage ofhigh ploidy
megakaryocytes than did all other mice. Also, male mice had significant higher
percentages of high ploidy megakaryocytes than did female mice. The megakaryocyte
DNA content for individual offspring of a given backcross appeared to form a single,
continuous distribution, rather than segregating into 2 distinct groups, suggesting that the
higher megakaryocyte DNA content of C3H mice is caused by involvement of multiple
alleles. This conclusion is further supported by their findings that the frequency of high
ploidy megakaryocytes among offspring of the various matings was related to the
proportion ofC3H genotype contributed by the parents.
DR. B. ROUSE continues his work to design delivery vehicles that optimize
induction of cytotoxic T lymphocytes with viral proteins and peptides. This program, in
collaboration with Dr. Leaf Huang, University of Pittsburgh, uses liposomes as the agent
carriers. This approach may prove a means to prevent virus infections in humans.

r

L

1

Benchmarks

14

Figure 1
Center of Excellence in Livestock Diseases and Human
Health External Funding Levels Since Establishment

93-94
92-93
91-92
$2,802,217

90-91
U)
~

ctS

~

89-90
88-89
87-88
86-87
85-86
84-85
$0

$1,000,000

$2,000,000

$3,000,000

II.
TABLE

BENCHMARKS

1. CENTER OF EXCELLENCE IN LIVESTOCK DISEASES AND HUMAN HEALTH
BENCHMARKS OF FACULTY ACCOMPLISHMENTS
FACULTY MEMBERS ASSOCIATED
WITH THE CENTER OF EXCELLENCE

YearS

Year 6

(Final Year of
Initial Commitment)

(Year 01 as
Accomplished

Center)

Center)

1991-92

1992-93

YearS

Year 7
(Year 02 as
Accomplished
Center)

1988-89

(Year 03 as
Accomplished
Center)

1991-92

Year 9

Year 10

(Year 04 as
Accomplished
Center)

(Year 05 as
Accomplished
Center)

1992-93

1994-95
~

Target Actual Avg

Actual

Avg

Actual

Avg

Actual

Avg

Actual

Avg

Actual

~

Avg

~

A. NUMBERS OF

(':>

74

1. ARTICLES

(3.22)

68

(2.62)

97

(3.73)

83

(4 .37)

78

(3.90)

7

(0.30)

17

(0.65)

14

(0.54)

6

(0.32)

7

(0.35

~

(.QJt1)

n

(1A2)

42

(1.&2)

24

(1 .26)

11

2.82

102

(4.43)

122

(4 .69)

153

(5.89)

113

(5.95)

1. REGIONAL MEETINGS

0.50

36

(1 .56)

19

(0.73)

28

( 1.08)

13

2. NATIONAL MEETINGS

1.25

55

(2 .39)

28

(1.08)

44

(1 .69)

0.30

33

(1.43)

66

(2 .54)

48

2. BOOKS OR BOOK CHAPTERS
PUBLISHED
3. PUBLISHED PROCEEDINGS

TOTAL PUBLICATIONS:
B. *NUMBER OF INVITED
PARTICIPATIONS AT:

C. ABSTRACTS

I

NUMBER OF FACULTY INCLUDED
IN CENTER
NUMBER OF VISITORS

11

95

I

(5.00)

9

(0.47)

(0.85)

11

@..5..8.).

102

(5.10)

104

(5.47)

(0.68)

15

(0.75)

18

(0.95)

36

(1 .89)

47

(2 .35)

47

(2.47)

(1.85)

47

(2.47)

53

(2 .65)

55

(2 .89)

23

26

26

19

20

19

10

17

17

12

12

13

;:s-.
~
~

I

"'l
;>;0

c.,

U1

Benchmarks

16

TABLE 2 .
RESEARCH PROJECTS FUNDED EXTERNALL Y
REPORT PERIOD 1993-94

PROJECT DIRECTOR

SOURCE
EXPENDITURES

TOTAL AMOUNT ESTIMATED
AWARDED
EXPENDITURES
7-1-93/6-30-94

BOCHSLER, P. N.
Bovine Lipopolysaccharide Binding
Protein and Mechanisms of
Macrophage Activation

USDA
9/1 /91-8/31/93
(Extension to 8/31/94)

140,000 --------------- 21 ,740

BOCHSLER, P. N.
Molecular Basis ofEndothelial Cell
Sensitivity to Lipopolysaccharide

USDA
911 5/92-9/30/94

95,000 --------------- 47,496

BOCHSLER, P. N.

USDA
911 5/92-9/30/94

150,000 --------------- 75,000

NIH
911/89-8/31194

549,224 --------------1 I 1,773

USDA
911 5/92-9/30/95

200,000 --------------- 66,660

The Bovine CD 14 Receptor: A Link in
Endotoxin-mediated Macrophage Activation
BRIAN, D. A.

Coronavirus Structure and Replication
BRIAN, D. A.

Mechanism(s) ofCoronavirus
RNA Replication and Packaging

Beckman Laser
SDI-MFEL Consortium
711/93-6/30/94

15,000 --------------- 15,000

Beckman Laser
Institute & Med Ctr
9/1/93-3/1/94

15,000 --------------- 15 ,000

GODKIN, J. D.
Retinoid Binding Proteins and
Receptors in Bovine Placental Development

USDA
911/93-8/31/96

212,000 --------------- 52,999

HAHN,K.A.
FRAZIER, D. L., Co-investigator

AAHA
7/1/94-6/30/96

10,000 ---------------------- 0

BYK Gulden
Pharmaceuticals
1/1/93-12/31/95

63,890 --------------- 21 ,300

Genentech
3/1/88-2/28/93
(Extension to 2/28/95)

175,832 --------------- 25,116

FRAZIER, D. L.

Transport ofPhotosensitizers Across the
Blood Brain Barrier
FRAZIER, D. L.
Analysis ofthe Photosensitizer HPPH

Phase II Evaluation ofDoxorubicin in the Cat
HAHN,K.
SCHULLER, H. M., Co-investigator

Contract--B859-035 Treatment ofDogs with
Osteosarcoma
MCDONALD, T. P.
Contract--Development ofAssays for
Thrombopoietin
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TOTAL AMOUNT ESTIMATED
AWARDED
EXPENDITURES
7-1-93/6-30-94

Genentech
3/ 1/88-7/31/93
(Extension to 2/28/95)

112,700 --------------- 16,104

AMGEN
10/1 /92-12/31 /95

73,671 --------------- 22,668

P.
Thrombopoietin: Immunoassay &
Characterization

NIH
12/1/88-11/30/93
(Extension to 11/30/94)

548,681 --------------- 81 ,837

T. P.

NHLBI Small
Instrumentation Program
8/1/93-7/31/94

22,818 --------------- 22,818

NIEHS
5/1/94-4/30/97

343,804 --------------- 22,402

L.
The Pathological Effects ofMelengestrol
Acetate in Captive Wild FeUds

AAZPA
Conservation Center
10/1/92-9/30/93

37,807 -----------------9,453

MUNSON,

L.
Effects ofProgestagen Contraceptives on the
Uterus and Mammary Glands ofExotic FeUds

Nixon Griffis Fund
3/1/91-2/28/94

2,843 ------------------- 632

MUNSON, L.
Continuing Safety Assessments of
Contraceptives for Non-domestic FeUds

AAZPA
Conservation Center
3/14/94-3/14/9 5

38,087 --------------- 11,109

S. P.
Mastitis Research

AIcide Corporation
12/90-12/94

57,752 --------------- 14,438

OLIVER, S. P.
Mastitis Research

H. B. Fuller Co.
4/91-12/94

31,778 -----------------8,664

Upjohn Company
1991-1994

54,225 --------------- 14,056

BASF
1992-1994

17,000 -----------------5 ,000

T. P.
Performance ofAssays for Thrombopoietin

McDoNALD,

T. P.
Characterization of Thrombopoietin
MCDONALD,

McDoNALD, T.

McDoNALD,

Purchase of: Nikon Labophot Fluvor
Dual Filter Microscope

S.
Role of Oncogenes in Transplacental
Lung Carcinogenesis

MILLER, M.

MUNSON,

OLIVER,

S. P.
Immunization ofdairy cows against
StreDtococcus ~: Efficacy ofan
Experimental Vaccine during the
Nonlactating Period
OLIVER,

S. P.
Selenium and Vitamin E in
Disease Resistance
OLIVER,
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OLIVER, S. P.
Use ofGenetic Markers as Indicators
ofMastitis Resistance and Milk
Production in Jersey Cattle
OLIVER, S. P.
Intramammary infusion ofAlcide for
treatment ofclinical mastitis in dairy cows
OLIVER, S.P.
Macrophage phagocytosis of
Streptococcus uberjs
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TOTAL AMOUNT ESTIMATED
AWARDED
EXPENDITURES
7-1-93/6-30-94

Amer Jersey
Cattle Club
1993-94

6,000 --------- 3,000

A\Cide Corporation
1993-94

14,167 --------- 7,085

Upjohn Company

8,000 --------- 4,000

1994-95

POTGIETER, L.
SigniJicance ofStrain Variation within the
Ruminant Respiratory Syncytial Virus
POTGIETER, L.
Cloning and Sequencing ofBRSV G
Glycoprotein and Detection ofStrain
Divergence

USDA
9/1 /93-8/3 1/95

123,3 10 -------- 5 1,380

USDA Special Grant

149,974 --------- 4,165

8/1 /90- 7/3 1/93

ROUSE, B. T.
Immunity Mechanisms in Herpes Virus Infections

NIH
5/1 /89-4/30/94

1,130,370------ 197,670

ROUSE, B. T., Advisor for D. Bouley
Herpetic Stromal Keratitis Pathogenesis:
An Animal Model

NIH Training Grant
7/1 /93-6/30/95

110,168 -------- 35,300

ROUSE, B. T.
Mechanisms in Herpetic Stromal Keratitis

National Eye
Institute (NIH)
9/30/92-9/29/97

774,745 ------ 200,217

ROUSE, B. T.
Liposome Microencapsulation of Vaccine
Antigens

NIAID
611 /90-5/31/95

828,289 ------ 166,235

ROUSE, B. T.
Mucosal Immunity in Control ofHerpetic
Infection

NIAID
811 /93- 7/31/96

562,404 ------ 160,534

ROUSE, B. T.
Herpes ZosteriJication
ROWLEST. K.
Characterization Isolated Rodent
MicrovesselslAstrocytes Co-cultures

SmithKline Biological
12/15/89-12/31/94
Environmental Protection
Agency (EPA)
417/93-4/6/95

124,746 --------------- 25,000

9,484 -----------------4,740
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TOTAL AMOUNT ESTIMATED
A WARDED
EXPENDITURES
7-1-93/6-30-94

ROWLEST. K.
Evaluation ofRenal and Neural
Function in Diving Mammals using in
vitro and in vivo Techniques

Office of Naval
Research
6/1/94-5/31/95

36,833 -----------------3,069

SCHULLER, H. M.
Mechanisms ofNeuroendocrine Lung
Carcinogenesis by Nitrosamines

Shannon Award
Institute (NIH)
9/1 /91-8/31/93

100,000 -----------------8,332

SCHULLER, H. M.
Characterization ofInduced Neuroendocrine
Lung Cancer

National Cancer
Institute (NIH)
2/7/92-1/31/95

464,975 --------------170,144

SCHULLER, H. M.
Contract--Testing ofAnti-carcinogenic
Effects ofNiguldipine

8yk Gulden
Pharmaceuticals
3/1/88-12/31/94

382,925 --------------- 52,497

SCHULTZ, T. W.
Photo-inducted Toxicity ofSubstituted
Anthracenes

University of Minnesota
1/15/94-1114/95

SHULL, R.
Molecular Study ofMPS I: Gene Therapy
in a Canine Model

NIH
8/1 /92- 7/31196

9,525 -----------------4,700

1,001,653 --------------123,342

SLAUSON, D. O.
Leukocyte Function and Host Defense
in Developing Calves

USDA Competitive
8/15/90-8/30/92
(Extension to 8/30/93)

120,000 --------------- 35,499

SLAUSON, D., Advisor for D. Dean
Signaling Pathways in LPS-Stimulated
Lung Macrophages

NIH Training Grant
11130/91-11/30/94

97,500 --------------- 33,800

G1axo Inc .
10/1 /93-9/30/96

672,890 --------------- 72,747

NIH

444,816 --------------160,944

WILKINSON, J. E.
Directed Expression ofthe Agouti Gene
Product in Transgenic Mice: A Potential
Model for Obesity
WILKINSON, J. E.
Molecular Genetics ofPKD in the
Transgenic TG737 Mouse

9/30/92-9/29/95

WILKINSON, J. E.
Immunobiology ofthe Scurfy Mouse

9/30/92-5/31/95

NIH
TOTAL

633,875 --------------249,083
$2.454,748
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III. PLANS FOR NEXT YEAR

CARCINOGENESIS AND DEVELOPMENTAL THERAPEUTICS GROUP
DR. H. SCHULLER will continue to pursue research in lung carcinogenesis. In particular,
she will expand her studies in neuroendocrine tumors and anti-cancer therapeutics of the
calcium channel blocker, Dexniguldipine.
DR. M. MILLER's goals for the coming year are to work with Dr. D. Schaeffer in
performing i.p. injections in pregnant mice and establish the breeding colony needed for his
project on the role of onocogenes in transplacental carcinogenesis. Moreover, he will be
standardizing the research protocol to extract DNA from paraffin embedded mouse tissues and
begin the molecular biology analyses.
This coming year, DR. K. HAHN will continue his work, therapeutic efficacy of
chemotherapy. Assisted by support from Bristol Laboratories and the National Cancer
Institute with donated drugs, he will seek to determine if differences in cellular pH and/or
glutathione concentrations in normal lymphocytes or mammary carcinoma cells in vitro
quantitatively affect etanidazole (SR-2508), an oxygen-mimetic nitroimidazole, sensitization
of cytotoxicity to selected chemotherapeutics including bleomycin, cisplatin, and doxorubicin.
GROWTH FACTORS AND MOLECULAR GENETICS GROUP
DR. E. WILKINSON plans a number of functional studies on the cultured Tg737 kidney
cells to further define their characteristics. Further, the Tg737 gene will be replaced in the
cultured cells by standard methods to precisely determine the effect of the Tg737 gene on cell
structure and function. Additionally, they will use mammalian expression vectors with
inducible promoters to turn the Tg737 gene on and off and study the function . A number of
vectors containing mutations in specific regions of the Tg737 protein will be engineered as a
basis for further studies of the structure and function of the protein. Finally, a number of in
vivo studies using the cultured liver cells will be conducted.
DR. R. SHULL will continue the gene therapy and recombinant enzyme trials.
Modifications of existing in vitro techniques for transferring the gene for the missing enzyme
to several cell types will be investigated. In addition to bone marrow cells, he will attempt to
use skin fibroblasts and myoblasts from skeletal muscle as targets for gene therapy. These
cell types have the advantage of easier transfection with retroviral vectors and have been
shown to secrete lysosomal enzymes. One or more dogs with MPS I will also be treated with
injectible enzyme in trials lasting 6-12 months. The goal will be to see if beneficial effects
can be realized in a broader range of tissues than in the first attempts that only lasted 13
weeks.
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Work planned for the coming year in DR. T. McDoNALD ' s laboratory focuses primarily
on investigating the mode of inheritance of the higher degree of megakaryocyte
polyploidization in C3H mice. They will also examine the effects of large doses of TPO on
platelet production in mice, complete work on the effects of vincristine on megakaryocyte
complexes and other cytoplasmic abnormalities in megakaryocytes and platelets of rats, and
investigate the role of genotype genomic imprinting and sex hormones in platelet and
megakaryocyte production.
During the next fiscal year, DR. C. MENDIS-HANDAGAMA will continue to focus her
efforts on understanding the mechanisms involved in movement of peroxisomes towards
mitochondria for cholesterol delivery.
DR. J. MERRYMAN will join the GFMG group this coming year. Her work will focus on
understanding the control of proliferation in cancer cells. Control of cellular proliferation is
exerted at the G 1IS interface of the cell cycle by certain growth factors, cyclin-dependent
protein kinases, and nuclear phosphoproteins such as the product of the retinoblastoma gene,
p105-Rb. Parathyroid hormone-related protein (PTHrP) is a newly identified calciotropic
hormone that causes the important paraneoplastic syndrome humoral hypercalcemia of
malignancy. In addition PTHrP has also been shown to be an autocrinelparacrine factor in
control of cellular proliferation in normal and malignant cells. The purpose of this
investigation is to evaluate human tumor cell lines for production of PTHrP and expression of
PTHrP receptors, and to examine the effects of PTHrP on cellular proliferation. These
investigations will prove useful in understanding control of proliferation in neoplastic cells, a
timely and important topic in the field of cancer biology, and will serve as a starting point for
more in-depth investigations in this critical area of cancer research.
DR. L. MUNSON will continue her research on the role of PDGFs in bovine placental
growth and the Patch mouse model. Studies examining the interaction of PDGF and retinoic
acid will be continued. Moreover, collaborations with the UTK Medical Center include
molecular analysis of normal, endometriotic, and malignant human endometrial epithelium to
determine if PDGF -a and PDGF -b receptors are present as well as research into the effects of
POGF in endometrial hyperplasia and neoplasia.
DR. J. GODKIN plans to complete his investigations on the role of retinoids, binding
proteins and receptors in embryonic development and uterine function. Work will continue
on interaction of transforming growth factors and retinoids in uterine function and embryonic
development. He also proposes to examine the role of retinoids in ovarian and oviduct
function.

IN VITRO TOXICOLOGY AND TOXICOKINETICS GROUP
DR. T. SCHULTZ will continue his studies on predictive toxicology. Work will involve
toxicity testing, molecular descriptor evaluation, and structure-toxicity relationship
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development of bioreactive chemicals. Efforts will center on the development and validation
of a computer aided structure evaluation (CASE) approach to identify toxicophores associated
with bioreactivity.
For DR. T. ROWLES, next year' s work will involve further development of protocols for
the in vitro assessment of neurotoxicity and testing of selected toxicants.
DR. D. FRAZIER will be working to develop an in vitro model of the kidney. This model
will be used for evaluation of transport and cytotoxicity of environmental toxicants and cancer
chemotherapeutics.
DR. D. WARD, a new member of the Center this coming year, in conjunction with DR.
SCHULTZ will continue his work begun in March of this year on the development and testing
of blood ocular barriers.
INFECTIOUS DISEASES AND POPULATION MEDICINE GROUP
Work in DR. L. POTGIETER'S laboratory will continue on several projects .. They will
continue to investigate the protective nature of the structural proteins of BVDV individually
and in combination with one another, as well as continue efforts to develop economical and
accurate diagnostic assays. In the next year, they will also continue work on ruminant RSV .
Specifically, they plan to identify subgroups within the RSVs using monoclonal antibodies in
an ELISA system of identification and to assess the significance of strain variation within the
RSV s. Moreover, they will be working on projects that involve immunostimulatory effects of
ivermectin in dogs, immunology of dogs with generalized demodicosis, and development of
improved methods for detecting feline immunodeficiency virus.
DR. S. OLIVER and his co-workers will continue to focus on development of RAPD
fingerprinting which has the potential to be a routine bacterial species identification method.
They plan on evaluating commercially available oligonucleotide primers and develop a
tentative species identification scheme.
DR. J. OLIVER and associates will, in the next year, further characterize specific alkaloid
effects on vascular biogenic amine receptors following chronic alkaloid infusion and
endothelial cells. They also will examine adrenal function in cattle on endophyte-infected
pasture. It is hoped that this next year will also see patent approval for an anti-fescue
toxicosis vaccine.
DR. D. BRIAN ' S research over the next 12 months will focus on developing the
coronavirus sUbgenomic replicon as a delivery vehicle for stimulating mucosal immunity and
as a vehicle for other direct-hitting antiviral molecules.
INFLAMMA TION AND HOST DEFENSE GROUP
will continue to investigate factors involved in the response of cattle
to endotoxin produced by gram-negative bacteria. Their plans include further studies with
DR. P. BOCHSLER

Plans for Next Year
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bovine lipopolysaccharide-binding protein that they have isolated and defining methods for
the identification of the bovine CD 14 receptor molecule. This receptor appears to be
important in the response of cattle to endotoxin. In addition, they will examine the roles of
interleukin-6, superoxide anion, and nitric oxide in bovine inflammation and host defense.
Studies of endotoxin and important bovine immunoregulatory molecules will yield a better
understanding of the bovine response to pathogens, and will eventually lead to improved .
methods of disease prevention and therapy.
The specific goals for DR. B. ROUSE include working on in sill! hybridization methods in
order to further characterize the cytokine profile (gene expression) and viral gene expression
during the course of HSK. This is to identify and localize the cells involved in the
immunopathology of HSK. Towards this end, he and his associates have developed specific
probes for the detection of viral genes, inflammatory cytokine genes and T cell derived
cytokine genes. Studies will also be conducted in an effort to detect selected cytokines and
genes of cornea obtained during various stages of the development of HSK.
During the next year DR. D. SLAUSON will continue to dissect the signaling pathways
used by LPS and LPS/LBP complexes for procoagulant induction and TNF -a release in
bovine lung macrophages with special attention directed at the potential role of a G-protein
linked receptor in the proximal pathway and a C-kinase as a terminal activator.
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Position Title

Birthdate

Joyce Irene Merryman
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October 28, 1953

Education

Deuee

Field of Study

Hocking Technical College
The Ohio State University
The Ohio State University
The Ohio State University

A.D. Nursing
B.S.
D.V.M.
Ph.D .

1978
1983
1987
1993

Nursing
Zoology
Veterinary Medicine
Pathobiology

Professional Experience
1993-Present Assistant Professor, Department of Pathology, University of Tennessee College of
Veterinary Medicine.
1989-1993

National Research Service Award, National Cancer Institute, studying the role of humoral
factors in the pathogenesis of humoral hypercalcemia of malignancy.

1989-1993

Graduate Research Fellow, The Ohio State University, Department of Veterinary
Pathobiology pursuing advanced research training leading to completion of the Ph.D degree
in Experimental Pathobiology.

1987-1989

Schering Plough Corporation Fellow/Resident, The Ohio State University, Department of
Veterinary Pathobiology pursuing research training leading to a Ph.D. degree in
Experimental Pathobiology and specialty training leading to Board Certification by the
American College of Veterinary Pathologists.

1985-1986

Student Research Associate, The Ohio State University, Department of Veterinary
Pathobiology, in the laboratories of C.C. Capen and T.J. Rosol

1980-1985

Registered Nurse, Grant Hospital, Columbus, Ohio, Surgical and Trauma Critical Care

1978-1980

Registered Nurse, The Ohio State University Hospitals, Cardiovascular Surgical Nursing

Professional Teachin& Experience
1987-1992

Graduate Teaching Associate in applied Veterinary Pathology, (Necropsy training for
professional students).

1991

Graduate Teaching Associate in Dermatopathology (Dermatology core curriculum course
for professional students) .

Professional Honors
National Research Service Award, National Cancer Institute, "Humoral Factors and Hypercalcemia of
Malignancy", 1989-1992
Schering Plough Corporation Fellow, 1987-1989
Finalist, Graduate Research Forum, The Ohio State University, 1989
Phi Zeta National Veterinary Honorary, 1986-present
Phi Zeta Research Award, The Ohio State University, College of Veterinary Medicine, 1987
Graduated summa cum laude, The Ohio State University, College of Veterinary Medicine, 1987
Second Place, American College of Veterinary Pathologists Young Investigator Award, 1993

Professional Societies
Phi Zeta, 1986-present
American Veterinary Medical Association, 1981-present
American Society for Bone and Mineral Research, 1989-present

Publications in Peer-Reviewed Journals
Merryman, J.I., Rosol, T.J., Brooks, C.L., and Capen, C.C.: Separation of parathyroid hormone-like
activity from transforming growth factor (TGF) -a and -6 in the canine adenocarcinoma (CAC-8)
model of humoral hypercalcemia of malignancy. Endocrinology, 124:2456-2463, 1989.
Rosol, T.J., Merryman, J.I., Nohutcu, R.M., McCauley, L.K., and Capen, C.C.: Effects of
transforming growth factor-a on parathyroid hormone- and parathyroid hormone-related protein
mediated bone resorption and adenylate cyclase stimulation in vitro. Domestic Animal
Endocrinology 8:499-507, 1991.
McCauley, L.K., Rosol, T.J., Merryman, J.I., and Capen, C.C.: Parathyroid hormone-related protein
binding to human T-celllymphotropic virus type I-infected lymphocytes. Endocrinology 130:300
306, 1992.
Rosol, T.J., Steinmeyer, C.L., McCauley, L.K., Merryman, J.I., Werkmeister, J.R., Grone, A.,
Weckman, M.T., Swayne, D.E., and Capen, C.C.: Characterization of chicken polyclonal anti
peptide antibodies specific for human parathyroid hormone-related protein (1-36). VeterinaIY
Immunology and Immunopathology 35:321-338, 1993 .
Merryman, J.I., Rosol, T.J., Werkmeister, J.R., McCauley, L.K., Suter, M.M., and Capen, C.C.:
Regulation of parathyroid hormone-related protein production by a squamous carcinoma cell line
in vitro. Laboratory Investigation, 69:347-354, 1993 .

Fenger, C.K., Bertone, J.J., Biller, D., Merryman, J.1.: Generalized medullary infarction of the long
bones in a horse. Journal of the American Veterinary Medical Association, 202:621-623, 1993.
Werkmeister, I.R., Merryman, J.I., McCauley, L.K., 1, Horton, J.E., Capen, C.C., Rosol, T.J.:
Parathyroid hormone-related protein production by normal human keratinocytes in vitro.
Experimental Cell Research, 208:68-74, 1993.
Merryman, J.I., Rosol, T.J., Capen, C.C.: Effects of gallium nitrate in nude mice bearing a canine
adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy. Journal of Bone and
Mineral Research, 9:725-732, 1994.
Merryman, J.I., Dewille, J., Werkmeister, J.R., Capen, C.C., Rosol, T.J.: Effects of transforming
growth factor-beta on parathyroid hormone-related protein production and RNA expression by a
squamous carcinoma cell line in vitro. Endocrinology, 134:2424-2430, 1994.
Okada, H., Merryman, J.I., Rosol, T.J., Capen, C.C.: Effects of humoral hypercalcemia of malignancy
and gallium nitrate on thyroid C-cells in nude mice: immunohistochemical and ultrastructural
investigations. Veterinary Pathology, 31 :349-357, 1994.
Okada, H., Merryman, J.I., Rosol, T.J., Capen, C.C.: Ultrastructural and histomorphometric evaluations
of the effects of gallium nitrate on bone in nude mice bearing a canine adenocarcinoma (CAC-8)
model of humoral hypercalcemia of malignancy. Veterinary Pathology, In Press, 1994.
Grooters, A.M., Miyabayashi, T., Biller, D.S., Merryman, J.: Sonographic appearance of uremic
gastropathy in four dogs. Veterinary Radiology and Ultrasound, 65:35-40, 1994.
Capen, C.C., Okada, H., Merryman, J.I., Rosol, T.J.: Effects of gallium nitrate in nude mice bearing
a canine adenocarcinoma model of humoral hypercalcemia of malignancy: biochemical,
histomorphometric, and ultrastructural investigations. Journal of Bone and Mineral Metabolism,
In Press, 1994.

Published Abstracts
Rosol, T.J., Capen, C.C ., Merryman, J.I., and Carpenter, G.: Inhibition of in vitro bone resorption by
a hypercalcemia adenocarcinoma (CAC-8) by a PTH receptor antagonist (8, 18Nle,l4Tyr
bPTH[3-34]). In: Abstracts of American Society of Bone and Mineral Research Meetings,
Indianapolis, IN, June 1987; and published in Journal of Bone and Mineral Research 2 [Suppl 1],
(1987): 86A.
Merryman, J.I., Rosol, TJ., and Capen, C.C.: Transforming growth factor activity in a canine tumor
line derived from an anal sac adenocarcinoma maintained in nude mice. In: Abstracts of Annual
Phi Zeta Research Day, Columbus, 15 May 1987.
Rosol, T.J., Capen, C.C., Merryman, J.I., Danks, J.A., Hayman, J., Ebeling, P.R., and Martin, T.J.:
Investigations on parathyroid hormone-related protein in canine anal sac adenocarcinoma and
infusion of PTHrP in nude mice. In: Abstracts of 39th Annual Meeting of American College of
Veterinary Pathologists, Kansas City, MO, 31 October-4 November, 1988, p. 13.

Merryman, J.I. and Capen, C.C.: Separation of parathyroid hormone-like activity from transforming
growth factors-a and -B in a canine adenocarcinoma (CAC-8) model of cancer-associated
hypercalcemia. In: Abstracts of 14th Annual Forum for Graduate Students in the Biological and
Health Sciences, The Ohio State University, 1989.
Merryman, J.I., Rosol, T.J., Capen, C.C.: Separation of parathyroid hormone-like activity from
transforming growth factor (TGF)-a and -B in a canine adenocarcinoma model (CAC-8) of
humoral hypercalcemia of malignancy (HHH). In: Abstracts (No. 805) of American Society of
Bone and Mineral Research/International Conference on Calcium Regulating Hormones First Joint
Meeting, Montreal, Quebec, 9-14 September 1989, and published in Journal of Bone and Mineral
Research 4 (Suppl. 1): S319, 1989.
Merryman, J.I., Rosol, T.J., and Capen, C.C.: Separation of parathyroid hormone-like activity from
transforming growth factors-a and -B in a canine adenocarcinoma model of humoral hypercalcemia
of malignancy. In: Proceedings of 40th Annual Meeting of American College of Veterinary
Pathologists, Baltimore, MD, 1-4 November 1989, p. 45.
Rosol, T.J., Merryman, J.I., Martin, S.L., and Capen, C.C.: Adenocarcinoma derived from specialized
cutaneous diverticula (anal sac) in dogs associated with persistent hypercalcemia: Clinical,
pathologic, ultrastructural, immunohistochemical, and in vitro studies. In: Abstracts of First
World Congress on Veterinary Dermatology, 28-30 September, 1989, Dijon, France, p. 28; and
published in Advances in Veterinary Dermatology, Vol. I. (C. von Tschamer and R.E.W.
Halliwell, Editors), Bailliere Tindall, London, 1990, p. 445.
Rosol, T.J., Merryman, J.I., McCauley, L.K., Steinmeyer, C.L., Swayne, D., and Capen, C.C.:
Characterization of polyclonal and monoclonal antibodies to parathyroid hormone-related protein.
In: Abstracts (No. 481) of American Society for Bone and Mineral Research, Atlanta, GA, 28-31
August 1990; and published in Journal of Bone and Mineral Research 5 (Suppl. 1, 1990): p. S194.
Rosol, T.J., Merryman, J.I., McCauley, L.K., and Capen, C.C.: Effects of transforming growth factor
alpha on parathyroid hormone- and parathyroid hormone-related protein-mediated bone resorption
and adenylate cyclase stimulation in vitro. In: Proceedings of 41st Annual Meeting of American
College of Veterinary Pathologists, Phoenix, AZ, 10-14 December, 1990, p. 52.
Rosol, T., Merryman, J., McCauley, L., Werkmeister, J., Grone, A., Steinmeyer, C., Swayne, D.,
Capen, C.: Pathogenesis of cancer-associated hypercalcemia of malignancy: Characterization of
polyclonal antibodies to parathyroid hormone-related protein in chickens. In: Abstracts of the
Eighth International Workshop on Vitamin D. Paris, France 5-10 July 1991, p. 51 and Published
in: Vitamin D - Gene Regulation. Structure-Function Analysis. and Clinical Application. (A.W.
Norman, R. Bouillon, and M. Thomasset, Editors). Walter de Gruyter, Berlin/New York, 1991,
pp. 919-920.
Rosol, T., Merryman, J., McCauley, L., Werkmeister, J., Swayne, D., and Capen, C.: Pathogenesis
of humoral hypercalcemia of malignancy (HHM): Production of polyclonal antibodies to
parathyroid hormone-related protein (PTHrP) in chickens. In: Abstracts (No. 187) of 80th
Meeting of U.S. and Canadian Academy of Pathology, Chicago, 17-22 March, 1991; and
published in Laboratory Investigation 64, (1991): 33A.

Werkmeister, J., Rosol, T., McCauley, L., Merryman, J., Horton, J., and Capen, C.: Regulation of
parathyroid hormone-related protein in normal human keratinocytes. In: Abstracts of 20th Annual
Meeting of IADRIAADR (International/American Assn. of Dental Research), Acapulco, Mexico,
17-21 April, 1991; and published in Journal of Dental Research 70, (1991) : 312.
Merryman, J.I., Rosol, T.J., McCauley, L.K., and Capen, C.C.: Production of parathyroid hormone
related protein by two human squamous cell carcinoma cell lines in vitro. In: Abstract (No. 594)
of American Society for Bone and Mineral Research, San Diego, CA, 24-28 August, 1991; and
published in Journal for Bone and Mineral Research 6, (Suppl. 1, 1991): S232.
Werkmeister, J.R., Rosol, T.J., Merryman, J.I., McCauley, L.K., Horton, J.E., and Capen, C.C.:
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Abstract (No. 586) of American Society for Bone and Mineral Research, San Diego, CA, 24-28
August, 1991; and published in Journal for Bone and Mineral Research 6, (Suppl. 1, 1991): S230.
McCauley, L.K., Rosol, T.J., Lairmore, M.D., Merryman, J.I., and Capen, C.C.: Expression of
parathyroid hormone-related protein in human T cell leukemia virus type (HTLV-l) infected
lymphocytes. In: Abstract (No. 568) of American Society for Bone and Mineral Research, San
Diego, CA, 24-28 August, 1991; and published in Journal for Bone and Mineral Research 6,
(Suppl. 1, 1991): S226.
Rosol, T., Merryman, J., McCauley, L. , and Capen, C.: Transforming growth factor-alpha effects on
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on Vitamin D, Paris, France, 5-10 July, 1991, p. 169.
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Rosol, T.J., Merryman, J.I., McCauley, L.K., Werkmeister, J.R., Grone, A., Swayne, D., Steinmeyer,
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protein (1-36). In: Proceedings of 42nd Annual Meeting of American College of Veterinaty
Pathologists, Orlando, FL, 8-13 December, 1991, p. 57.
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In: Proceedings of 42nd Annual Meeting of American College of Veterinary Pathologists,
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McCauley, L., Rosol, T., Lairmore, M., Merryman, J., and Capen, C.: Modulation of parathyroid
hormone-related protein mRNA expression in T-Iymphocytes. In: Abstracts of Annual Meeting
of American Association of Dental Research, Boston, MA, 11-15 March, 1992; and published in
Journal of Dental Research 71, (1992): 212.
Werkmeister, J., Rosol, T., Merryman, J., McCauley, L., Horton, J., and Capen, C.: Regulation of
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Annual Meeting of American Association of Dental Research, Boston, MA, 11-15 March, 1992;
and published in Journal of Dental Research 71, 1992: 199.

Merryman, J.I., Werkmeister, J.R., Rosol, T.J., McCauley, L.K., Suter, M.M., and Capen, C.C.:
Parathyroid honnone-related protein production and receptor expression by nonnal and malignant
keratinocytes. In: Abstracts (No. 213) of 81st Meeting of U.S. and Canadian Academy of
Pathology, Atlanta, GA, 14-20 March, 1992; and published in LaboratOIY Investigation 66, 1992:
37A.
McCauley, L., Rosol, T., Lainnore, M., Merryman, J., and Capen, C.: Polymerase chain reaction
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Academy of Pathology, Atlanta, GA, 14-20 March, 1992; and published in Laboratory
Investigation 66, 1992: 83A.
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carcinoma cell line. Abstract of the 14th Annual Meeting of the American Society for Bone and
Mineral Research. Minneapolis. Mn .. 1992, and to be published in Journal of Bone and Mineral
Research, 1992.
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phenotype. Abstract of the 14th Annual Meeting of the American Society for Bone and Mineral
Research. Minneapolis. Mn .. 1992, and published in Journal of Bone and Mineral Research, 1992.
Merryman, J., Rosol, T., Dewille, J., Farmer, S., Werkmeister, J., Capen, C.: Stimulation of
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PRESENTATIONS
National and Reqional Heetinqs

American College of Veterinary Ophthalmologists, Fort Worth TX.
"Ocular granulomatous meningoencephalitis in a dog," November
1987.
American College of Veterinary Ophthalmologists, Las Vegas NV.
"Fluorophotometric evaluation of experimental acute anterior
uveitis in the dog," October 1988.
American College of Veterinary Ophthalmologists, San Diego CA.
"Comparison of the blood-aqueous barrier stabilizing effects of
steroidal and nonsteroidal antiinflammatory agents in the dog,"
November 21, 1992.
Johns Hopkins Center for Alternatives to Animal Testing,
Baltimore MD. "In vitro model of the blood-ocular barriers as an
aid in oculotoxicity testing," February 23, 1994.
continuinq Education seminars

Greenville Veterinary Medical Association, Greenville, SC.
"Canine glaucoma," 2 hours, January 1988.
East Tennessee Veterinary Medical Association, Gatlinburg, TN.
"Equine keratitis," 3 hours, October 3, 1992.
University of Tennessee College of Veterinary Medicine continuing
Education Conference, Knoxville TN. "Update on ophthalmic

drugs," 1 hour, December 7, 1992.
University of Tennessee College of Veterinary Medicine Feline
Club, Knoxville TN.
"Case presentations in feline
ophthalmology," 1 hour, September 15, 1993.
University of Georgia college of veterinary Medicine:
Physiology/Pharmacology Seminar

"Anterior segment slit-lamp fluorophotometry in the dog" 
February 1988.
"Experimental blood-aqueous barrier breakdown in the dog" 
November 1988.
university of Georgia college of veterinary Medicine:
Education Program.

continuing

"Inherited and Congenital diseases of the ocular fundus" 
February 1987.
university of Tennessee Intern/Resident seminar series

8 lectures, various ophthalmological topics, Spring 1991 .
..

"Ocular Emergencies" - July 1992.
"Keratitis" and "Anterior Uveitis" - February 1993.
"Ocular Emergencies" - July 1993.
"Corneal Opacification" and "Case Discussions" - February 1994
"Biostatistics" - 5 hour series 2/94 - 6/94
university of Tennessee Grand Rounds Series

"Odontogenic Keratocyst in a Dog" - AprilS, 1992.
"Ocular Blastomycosis in a Dog" - 1992.
"Myasthenia Gravis Presenting as Blepharoptosis in a Dog" 
Sept.10, 1993
Lay Audience Presentations

"Ocular emergencies" - Greater Atlanta Boxer Association,
February 1988.
"Ocular diseases affecting the Bulldog" - Atlanta Bulldog
Association, September 1989.
"Feline ophthalmology" - Knoxville Feline Club, February 20,
1992.

RESEARCH EXPERIENCE
Grants

"Chemomodulation of the canine blood-aqueous barrier:
Evaluation by fluorophotometry"
Principle author: Ward DA
Principle investigator: Kaswan RL
Co-investigators: Ward DA, Kaswan RL, Martin CL, Ferguson DC
Funding: Funded by the University of Georgia Veterinary
Medical Exp station, $5,100, June 1987
a.

Grant renewal funded by the University of Georgia
VMES, $2,000, June 1988.

b.

Grant renewal funded by the University of Georgia
VMES, $4,600, June 1989.

"A quantitative model of uveitis in the dog"
AVMA Foundation Research Grant Program
Principle author: Ward DA
Principle investigator: Kaswan RL
Co-investigators: Ward DA
Funding: Ranked in top 25% of 214 proposals submitted and
approved funding, but not funded due to limitation
of available funds.
"Comparison of ocular anti-inflammatory drugs in the dog:
Evaluation by fluorophotometry."
Solvay Resident Grant Competition, 1989
Principle author: Ward DA
Principle investigator: Ward DA
Funding: Selected as finalist in competition but not
selected as an awardee.
"Pharmacologic management of bood-aqueous barrier disruption
in dogs."
Principle investigator: Ward DA
Funding: UT Centers of Excellence, $5,000; Small Animal
Research, $3,000.
"Characterization of PGE2 receptors in canine iris-ciliary body
membrane preparations."
Principle investigator: Ward DA
Co-investigator: Frazier DA
Funding: UTCVM Venture Grant, $2,900; UTCVM Department of
Urban Practice, $1,000.
"Evaluation and comparison of two surgical techniques for
the treatment of canine glaucoma."
Principle investigator: Ward DA
Co-investigator: Morgan RV
Funding: Companion Animal Fund, $3,560.

"In vitro model of the porcine blood-aqueous barrier."
Principle investigator: Ward DA
Co-investigators: Rowles T, Frazier 0, Schultz T
Funding: UTCVM Venture Grant, $3,400.
"In vitro model of the blood-ocular barriers as an aid in
oculotoxicity testing."
Principle investigator: Ward DA
Co-investigaotrs: Rowles T, Frazier 0, Schultz T
Funding: Johns Hopkings Center for Alternatives to Animal
Testing, $30,000, 2/1/94.
"Isolation of and indirect immunofluorescent testing for
Chlamydia psittaci in cats with conjunctivitis."
principle investigator: Ward DA
Co-investigators: Kennedy M, Legendre A, Potgeiter L, Morgan R,
Grove C
Funding: Intervet, Inc., $5,000.
"Effect of topical demecarium bromide on systemic
acetylcholinesterase levels in dogs."
Principle Investigator: Ward DA
Co-investigators: Abney K, Israel J
Funding: UTCVM Companion Animal Fund, $382.10.
"The effects of topical 1% aproclonidine hydrochloride on the
intraocular pressure of normal canine subjects."
Principle Investigator: Ward DA
Co-investigator: Burgess H
Funding: UTCVM Small Animal Research, $1,760.
"In vitro model of the blood-ocular barriers as an aid in
oculotoxicity testing."
Principle Investigator: Ward DA
Funding: pendinq -- UTCVM Centers of Excellence, $15,681
requested 3/94.
"In vitro model of the blood-aqueous barrier as an aid in
oculotoxicity testing."
Principle Investigator: Ward DA
Co-investigator: Rowles TA, Frazier 0, Schultz TW
Funding: pendinq -- Fight for Sight, the Research Division of
the National Society to Prevent Blindness, $12,000 requested
3/94.
Current Investiqations

Evaluation and comparison of two surgical techniques for the
treatment of canine glaucoma.
Comparison of 3 surgical techniques for the treatment of canine
distichiasis.

Isolation of and indirect immunofluorescent testing for Chlamydia
psittaci in cats with conjunctivitis.
CONTINUING EDOCATION COURSES ATTENDED

American Society of Veterinary Ophthalmology, Atlanta, GA, June
1986.
American College of Veterinary ophthalmologists Annual Meeting,
Fort Worth, Texas, November 1987.
Basic Sciences Course in Ophthalmology, Stanford University
School of Medicine, Palo Alto, CA, July 1988-September 1988.
Phacoemulsification/Intraocular Lens Implantation Short Course,
University of California School of Veterinary Medicine, Davis,
California, June 1989.
American College of Veterinary Ophthalmologists Annual Meeting,
New Orleans, Louisiana, October 1989.
American College of Veterinary Ophthalmologists Annual Meeting,
San Diego CA, November 1992.
TEACHING EXPERIENCE

Small Animal General Surgery - SMS 540 (University of Georgia)
Assistance in ophthalmology portion of student surgery
laboratory, spring Quarter 1987 & 1988
Studies in Small Animal Clinical Medicine - SM 590 (University of
Georgia)
Clinical rotation in ophthalmology - Participation totaling
60 weeks during the period September 1986-September 1989
Small Animal Medicine - SMS 520 (University of Georgia)
Limited participation in didactic ophthalmology lectures,
1988 & 1989
Small Animal Medicine - SMS 521 (University of Georgia)
Limited participation in didactic pharmacology lectures,
1989
Special Senses - VM856 (University of Tennessee)
Didactic ophthalmology lectures (11) and laboratories (5),
Fall 1990, Winter 1992, Winter 1993, Winter 1994.
Veterinary Medical Technology - AS496 (University of Tennessee)
Technology used in the practice of veterinary ophthalmology
(1 hr), 4/15/93, 3/31/94.
COMMITTEE ASSIGNMENTS

College of Agriculture Advisory Council, student Development
Subcommittee, member, 1991 - present.
Postdoctoral/Resident Committee, member, 1992-present.
Educational computing Committee, member, 1993-present.
Committee to Formulate Guidelines for Visiting Foreign
Veterinarians, chairman, 1993.
MISCELLANEOUS

Mentor for ophthalmology section of UTCVM Open House, 1991, 1992,
1993.
Presentation on careers in veterinary medicine, Farragut High
School Career Day, Spring 1991.
Participant in UT Academy for Teachers of Science and Mathematics
program at UTCVM, July 8, 1992.
Arranged Departmental Christmas party, December 1992.
participant in UTCVM/Knoxville Zoo "Teddy Bear Picnic," July
1993.
Participant in UTCVM Field Day for West High School Physiology
Class, 3/3/93.
Tour of UTCVM for Blount County elementary school students,
1/28/94.
Active involvement in use of computer generated teaching methods:
Gave continuing education course using this format December 1992,
presented one lecture for VM856 using this format March 1994.
Presenter, 1993 Last Lecture Series on behalf of the Class of
1994.
Advisor, Student Chapter of the AVMA, 1993-present.
Tour of UTCVM for Leadership Education conference, 3/18/94.
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